220 related articles for article (PubMed ID: 24947251)
1. Sentinel lymph node biopsy in melanoma: final results of MSLT-I.
Durham AB; Wong SL
Future Oncol; 2014 May; 10(7):1121-3. PubMed ID: 24947251
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
[TBL] [Abstract][Full Text] [Related]
3. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
4. Melanoma sentinel lymph node biopsy and completion lymph node dissection: A regional hospital experience.
Williams TS; Tallon B; Adams BM
J Plast Reconstr Aesthet Surg; 2022 Feb; 75(2):730-736. PubMed ID: 34789434
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy for melanoma: indications and rationale.
Phan GQ; Messina JL; Sondak VK; Zager JS
Cancer Control; 2009 Jul; 16(3):234-9. PubMed ID: 19556963
[TBL] [Abstract][Full Text] [Related]
6. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
[TBL] [Abstract][Full Text] [Related]
7. No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.
Sladden M; Zagarella S; Popescu C; Bigby M
Br J Dermatol; 2015 Mar; 172(3):566-71. PubMed ID: 25776246
[TBL] [Abstract][Full Text] [Related]
8. Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature.
Sloot S; Speijers MJ; Bastiaannet E; Hoekstra HJ
Cancer Treat Rev; 2016 Apr; 45():120-8. PubMed ID: 27015564
[TBL] [Abstract][Full Text] [Related]
9. Management of the positive sentinel lymph node in the post-MSLT-II era.
Bredbeck BC; Mubarak E; Zubieta DG; Tesorero R; Holmes AR; Dossett LA; VanKoevering KK; Durham AB; Hughes TM
J Surg Oncol; 2020 Dec; 122(8):1778-1784. PubMed ID: 32893366
[TBL] [Abstract][Full Text] [Related]
10. New Zealand patients have a higher melanoma burden in sentinel nodes and completion lymphadenectomy than patients in MSLT-II.
Williams TS; Arahill-Whitham J; Bailey TA; Hayward G; Li A; Tallon B; Wen D; Adams BM
J Plast Reconstr Aesthet Surg; 2023 Aug; 83():98-105. PubMed ID: 37271003
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
12. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P
Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
[TBL] [Abstract][Full Text] [Related]
13. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
Bamboat ZM; Konstantinidis IT; Kuk D; Ariyan CE; Brady MS; Coit DG
Ann Surg Oncol; 2014 Sep; 21(9):3117-23. PubMed ID: 24833100
[TBL] [Abstract][Full Text] [Related]
14. Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.
Masoud SJ; Perone JA; Farrow NE; Mosca PJ; Tyler DS; Beasley GM
Curr Treat Options Oncol; 2018 Sep; 19(11):55. PubMed ID: 30232648
[TBL] [Abstract][Full Text] [Related]
15. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
Fritsch VA; Cunningham JE; Lentsch EJ
Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
[TBL] [Abstract][Full Text] [Related]
16. Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.
McMasters KM; Egger ME; Edwards MJ; Ross MI; Reintgen DS; Noyes RD; Martin RC; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Sussman JJ; Davidson BS; Gershenwald JE; Hagendoorn LJ; Stromberg AJ; Scoggins CR
J Clin Oncol; 2016 Apr; 34(10):1079-86. PubMed ID: 26858331
[TBL] [Abstract][Full Text] [Related]
17. Patients with sentinel lymph node positive melanoma: Who needs completion lymph node dissection?
Schuitevoerder D; Bubic I; Fortino J; Massimino KP; Vetto JT
Am J Surg; 2018 May; 215(5):868-872. PubMed ID: 29397888
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
19. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node biopsy in melanoma: Current controversies addressed.
Madu MF; Wouters MW; van Akkooi AC
Eur J Surg Oncol; 2017 Mar; 43(3):517-533. PubMed ID: 27590685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
